Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation

Aims  To establish a unified working diagnostic tool for the metabolic syndrome (MetS) that is convenient to use in clinical practice and that can be used world‐wide so that data from different countries can be compared. An additional aim was to highlight areas where more research into the MetS is needed.

[1]  P. Macfarlane,et al.  Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study , 2003, Circulation.

[2]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[3]  S. Haffner,et al.  The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. , 2003, Diabetes care.

[4]  L. Bouter,et al.  Insulin and risk of cardiovascular disease: a meta-analysis. , 1998, Circulation.

[5]  R. Rosenson,et al.  Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status. , 2004, Endocrinology and metabolism clinics of North America.

[6]  Warszawski Uniwersytet Medyczny,et al.  Diabetes care , 2019, Health at a Glance.

[7]  A Tremblay,et al.  Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. , 1994, The American journal of cardiology.

[8]  A. Wear.  CIRCULATION , 1964, The Lancet.

[9]  S. Lear,et al.  Modification of the relationship between simple anthropometric indices and risk factors by ethnic background. , 2003, Metabolism: clinical and experimental.

[10]  S. Kiechl,et al.  Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. , 1998, Diabetes.

[11]  J. Seidell,et al.  Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample , 1995, BMJ.

[12]  K. Reynolds,et al.  Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults. , 2004, The American journal of clinical nutrition.

[13]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[14]  L. Sjöström,et al.  XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. , 2004, Diabetes care.

[15]  C. Bouchard,et al.  Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[16]  J. Yudkin.  Adipose tissue, insulin action and vascular disease: inflammatory signals , 2003, International Journal of Obesity.

[17]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[18]  Bei-fan Zhou.  Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. , 2002, Biomedical and environmental sciences : BES.

[19]  B. Tomlinson,et al.  Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality , 2001, International Journal of Obesity.

[20]  T. Nakagami,et al.  Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin , 2004, Diabetologia.

[21]  James W. Anderson,et al.  Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT). , 2003, Diabetes care.

[22]  J. Després,et al.  Elevated C-Reactive Protein: Another Component of the Atherothrombotic Profile of Abdominal Obesity , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[23]  Jane B Shofer,et al.  Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. , 2004, Diabetes.

[24]  W. Shau,et al.  Optimal cut-off values for obesity: using simple anthropometric indices to predict cardiovascular risk factors in Taiwan , 2002, International Journal of Obesity.

[25]  N. Kaplan.  The Deadly Quartet: Upper-Body Obesity, Glucose Intolerance, Hypertriglyceridemia, and Hypertension , 1989 .

[26]  P. Underwood.  Cardiovascular risk, the metabolic syndrome and the hypertriglyceridaemic waist. , 2004, Current opinion in lipidology.

[27]  E. Tai,et al.  Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? , 2004, Diabetes care.

[28]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[29]  B. Balkau,et al.  The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. , 2003, Diabetes & metabolism.

[30]  Robert Atkins,et al.  The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. , 2002, Diabetes care.

[31]  T Nakamura,et al.  Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. , 1994, Atherosclerosis.

[32]  David V. Power,et al.  Standards of Medical Care in Diabetes: Response to position statement of the American Diabetes Association , 2006 .

[33]  M. Laakso,et al.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.

[34]  P. Björntorp,et al.  The Influence of Body Fat Distribution on the Incidence of Diabetes Mellitus: 13.5 Years of Follow-up of the Participants in the Study of Men Born in 1913 , 1985, Diabetes.

[35]  G A Colditz,et al.  Abdominal adiposity and coronary heart disease in women. , 1998, JAMA.

[36]  M. Walker,et al.  The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and Objectives , 2004, Diabetologia.

[37]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[38]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[39]  H. Tunstall-Pedoe,et al.  Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations , 1999, The Lancet.

[40]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[41]  Markolf Hanefeld,et al.  Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. , 2003, JAMA.

[42]  S. Haffner,et al.  Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? , 2004, Diabetes care.

[43]  J. Shaw,et al.  The metabolic syndrome: prevalence in worldwide populations. , 2004, Endocrinology and metabolism clinics of North America.

[44]  H. Tunstall-Pedoe,et al.  Changes in estimated coronary risk in the 1980s: data from 38 populations in the WHO MONICA Project. World Health Organization. Monitoring trends and determinants in cardiovascular diseases. , 1998, Annals of medicine.

[45]  J. Brunzell,et al.  Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. , 2004, The Journal of clinical endocrinology and metabolism.

[46]  R. Bilous,et al.  Cause-specific mortality in a population with diabetes: South Tees Diabetes Mortality Study. , 2002, Diabetes care.

[47]  Eiji Oda,et al.  New criteria for 'obesity disease' in Japan. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[48]  L. Niskanen,et al.  Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. , 2002, American journal of epidemiology.

[49]  B. Balkau,et al.  Comment on the provisional report from the WHO consultation , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[50]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.

[51]  Ken Williams,et al.  National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study , 2004, Circulation.

[52]  J. Manson,et al.  Body weight and mortality. A 27-year follow-up of middle-aged men. , 1993, JAMA.

[53]  Maria Inês Schmidt,et al.  The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. , 2005, Diabetes care.

[54]  E. Ravussin,et al.  Racial differences in the relation between blood pressure and insulin resistance. , 1991, The New England journal of medicine.

[55]  Ambady Ramachandran,et al.  Cutoff values for normal anthropometric variables in asian Indian adults. , 2003, Diabetes care.

[56]  C. Loria,et al.  Age and the burden of death attributable to diabetes in the United States. , 2002, American journal of epidemiology.

[57]  Y. Hu,et al.  Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population , 2002, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[58]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[59]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[60]  Jaakko Tuomilehto,et al.  The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. , 2003, Diabetes care.

[61]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[62]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[63]  J. Seidell,et al.  The public health impact of obesity. , 2001, Annual review of public health.

[64]  J. Tuomilehto,et al.  Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. , 2004, Archives of internal medicine.

[65]  C. Morrison,et al.  Waist circumference as a measure for indicating need for weight management , 1995, BMJ.

[66]  S. Grundy,et al.  Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[67]  Caballero Ae.  Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes. , 2004 .

[68]  S. Kihara,et al.  Adiponectin and Metabolic Syndrome , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[69]  R. Durbin.  Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance , 2004, Diabetes, obesity & metabolism.

[70]  G A Colditz,et al.  Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. , 1997, American journal of epidemiology.

[71]  T. Buchanan,et al.  Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. , 2002, Diabetes.

[72]  S. Haffner,et al.  Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X) , 1992, Diabetes.

[73]  Y. Matsuzawa.  New Criteria for 'Obesity Disease' in Japan : The Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity , 2002 .

[74]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[75]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[76]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.